AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 59 filers reported holding AVADEL PHARMACEUTICALS PLC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $4,777,651 | +80.9% | 289,906 | +0.5% | 0.42% | +67.9% |
Q1 2023 | $2,641,057 | +299.6% | 288,325 | +91.5% | 0.25% | +287.7% |
Q3 2018 | $661,000 | -30.9% | 150,600 | -3.4% | 0.06% | -33.7% |
Q2 2018 | $956,000 | -37.6% | 155,971 | -25.7% | 0.10% | -41.7% |
Q1 2018 | $1,531,000 | +6.5% | 210,012 | +61.2% | 0.17% | -8.7% |
Q2 2017 | $1,437,000 | -19.3% | 130,311 | -29.1% | 0.18% | -20.3% |
Q1 2017 | $1,780,000 | – | 183,866 | – | 0.23% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WEALTH EFFECTS LLC | 2,305,017 | $18,625,000 | 7.73% |
COWEN AND COMPANY, LLC | 3,732,778 | $30,161,000 | 2.74% |
GENDELL JEFFREY L | 2,446,299 | $19,766,000 | 1.60% |
Asymmetry Capital Management, L.P. | 369,134 | $2,983,000 | 1.58% |
Vivo Capital, LLC | 2,937,093 | $23,732,000 | 1.43% |
Samsara BioCapital, LLC | 659,409 | $5,328,000 | 1.03% |
Altium Capital Management LP | 440,589 | $3,560,000 | 0.98% |
Knott David M Jr | 258,198 | $2,086,000 | 0.71% |
RTW INVESTMENTS, LP | 5,741,939 | $46,395,000 | 0.68% |
FRAZIER MANAGEMENT LLC | 951,814 | $7,691,000 | 0.59% |